Dr Andreea Ciudin describes the EASO Pharmacological Framework for obesity management - emphasising that medication is not the first component in obesity mgmt. And patient first approaches are crucial. Thank you for joining!
24/02/2026
You can join today’s COMs webinar on the EASO Framework and Algorithm now using the link below! 🌟
Join Prof Prof Barbara McGowan, Dr Andreea Ciudin and Prof Dror Dicker tomorrow for this important EASOCOMs Webinar ➡️ The 2025 EASO Algorithm for the Management of Obesity 🗓️ Tues 24 Feb 11:30am UK / 12:30pm Paris
TRANSFORM: Training Experts for Tomorrow ➡️ 15–17 March 2026 The Netherlands 🇳🇱
🌟 TRANSFORM is an educational training programme designed for early/mid-career medical specialists with a focus on obesity.
The programme has been developed by Professor Erica van den Akker and Professor Luca Busetto, with the goal of providing an interactive environment for attendees to collaborate with scientific leaders and their peers in the field, whilst gaining the latest knowledge and skills relevant to their day-to-day practice.
To ensure all delegates benefit from the programme, participants will be required to develop a short case study based on one key topic from the following:
✔️Clinical evaluation
✔️Diagnostics
✔️Treatment
The All-island Obesity Action Forum (Safefood) is hosting an event on how digital food marketing across social media, gaming and delivery apps influences eating behaviours and obesity risk.
🗓️24th February 2026, Belfast & online
Day 2 at the plenary in Bern 🇨🇭 the team are discussing how to clearly and responsibly communicate about (PRS) in the context of health 🧬
20/02/2026
Interesting changes in processed foods coming: shorter ingredient lists and smaller pack sizes in 2026 as more people take appetite-suppressing GLP-1 medications.
Companies that previously took a wait-and-see attitude now see GLP-1s as here to stay HT
Global food and beverage companies from PepsiCo to Coca-Cola are focusing on shorter ingredient lists and smaller pack sizes in 2026 as more people take appetite-suppressing GLP-1 drugs for weight loss.
20/02/2026
Ambient Air Pollution Is Particularly Associated with Visceral Fat Accumulation in Men: A Large-Scale Korean Adult Study in Obesity Facts
Meet the EASO COM Division of Pediatric Endocrinology and Diabetes at the Department of Paediatrics and Adolescent Medicine, University Medical Center Ulm, Germany, led by Prof Martin Wabitsch 🇩🇪
This COM is internationally recognised for
✔️Excellence in childhood and adolescent obesity research and care
✔️Advanced clinical practice with strong national and European collaborations.
✔️Patient care philosophy and approach
Learn more about this COM and
✔️Treatments and services offered
✔️How they engage with the wider community and health system
✔️Their challenges and goals for the next 3–5 years ✔️Recent achievements and research updates
Be the first to know and let us send you an email when EASOobesity posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.
The EASO medical and scientific community all across Europe is intensively engaged in addressing the global COVID-19 pandemic. Our clinicians are working in the front line of care daily for patients living with obesity within emergency care systems, in coordination with other clinical colleagues across 34 countries. Our scientists are hard at work developing tools and frameworks for contributing to psychological support for clinicians and patients, developing and implementing public health strategies, providing guidance and support for whole family assistance, and development and provision of advice for children and teens.
Our role in this crisis will be crucial in the dissemination of science-based information and providing common-sense, evidence-based updates, recommendations and guidance via our website and social media, that can reach millions of people. EASO is committed to sharing only the latest well evidenced information and guidance from credible sources.
People living with the chronic disease obesity are particularly vulnerable to the effects of the novel coronavirus, and appear to have a higher rate of serious complications from the virus. It is paramount that people with obesity avoid infection. We herein recommend that people with obesity shelter at home during this time, following their national guidance for vulnerable people living with chronic disease.
Infographics developed in conjunction with our scientific and patient communities focused on energy balance; mental health; family life with children and adolescents;and indoor exercise, all helpful during COVID-19, are available for download on the EASO website.